HLS Therapeutics Inc
OTC Pink - Current Information:HLTRFView on Canadian Exchange

  • LAST PRICE
    2.4300
  • TODAY'S CHANGE (%)
    0.1050 (4.5161%)
  • Bid / Lots
    2.4700/ 79
  • Ask / Lots
    2.5600/ 38
  • Open / Previous Close
    2.4900 / 2.3250
  • Day Range
    2.4300
    2.4900
  • 52 Week Range
    2.2200
    4.0000
  • Volume
    300

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

Charts

Price Comparison Graph. See accessible table below
Data delayed at least 15 minutes.

Industry Peers

CompanyMarket CapP/E Ratio (TTM)EPS Growth (5yr)
HLTRF
HLS Therapeutics Inc
105.2M
---
---
As of 2024-11-22

Company Information

HLS Therapeutics Inc. is a pharmaceutical company focused on the acquisition and commercialization of late-stage development, commercial stage promoted and established branded pharmaceutical products in the North American markets. It is engaged in addressing unmet needs in the treatment of psychiatric disorders and cardiovascular disease. It is also focused on products targeting the central nervous system and cardiovascular therapeutic areas. Its products include Clozaril, CSAN Pronto, MyCare Psychiatry and Vascepa. Its Clozaril is an atypical antipsychotic indicated for the management of symptoms of treatment-resistant schizophrenia for the Canadian and United States markets. CSAN Pronto is a capillary point-of-care medical device designed to enhance and simplify the mandatory safety blood monitoring process for patients that are prescribed Clozaril. The Vascepa (icosapent ethyl capsules) is a single-molecule prescription product in use to reduce the risk of cardiovascular events.

Contact Information

Headquarters
10 Carlson Court, Suite 701ETOBICOKE, ON, Canada M9W 6L2
Phone
647-495-9000
Fax
647-495-9000

Executives

No data available

Ratings

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Reports

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals

Market Cap
---
Revenue (TTM)
---
Shares Outstanding
---
HLS Therapeutics Inc does not pay a dividend.
Beta
---
EPS
---
Book Value
---
P/E Ratio
---
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Calendar

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.